Although the incidence of abdominal aortic infection is low, conventional treatment is complex and the outcome can be devastating.  The use of synthetic graft alternatives are often not an option for placement directly in to an infected field.  Conventional treatment methods, such as an extra-anatomical bypass procedure, have clinically demonstrated to be a costly and clinically inefficient option when compared to the outcomes achieved with CryoArtery aortoiliac allograft.  The best option to safely and effectively treat mycotic aneurysms, synthetic graft infections, and aortoenteric fistulas in an infected field is available with CryoArtery.